An initial clinical observations indicated Gal-3 as biomarker for decompensated heart failure, with incremental value over well-used “pressure-dependent” biomarkers, such as B-type natriuretic peptide (De Boer et al., 2010). The gene discussed is LGALS3; the disease is heart failure.